Kaempferol stimulates bone sialoprotein gene transcription and new bone formation

Journal of Cellular Biochemistry

Volumn 110, Issue 6, 2010, Pages 1342-1355

  Yang, Li ^a,b   Takai, Hideki ^a   Utsunomiya, Tadahiko ^a   Li, Xinyue ^a,b   Li, Zhengyang ^a,b   Wang, Zhitao ^a,b   Wang, Shuang ^a,c   Sasaki, Yoko ^a   Yamamoto, Hirotsugu ^a   Ogata, Yorimasa ^a  

^a NIHON UNIVERSITY   (Japan)

^b TIANJIN STOMATOLOGICAL HOSPITAL   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Bone formation; Bone sialoprotein; Flavonoid; Immunolocalization; Kaempferol; Osteoblasts; Transcription

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; ACETYLCYSTEINE; BONE SIALOPROTEIN; CCAAT PROTEIN COMPLEX; HERBIMYCIN A; KAEMPFEROL; LUCIFERASE; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NUCLEAR PROTEIN; NUCLEOTIDE; OSTERIX; RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; ESTROGEN ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; IMMUNOLOCALIZATION; NEWBORN; NONHUMAN; OSSIFICATION; PERIOSTEUM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RAT; SKULL; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE, TUMOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; INTEGRIN-BINDING SIALOPROTEIN; KAEMPFEROLS; LUCIFERASES; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; OSTEOGENESIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIALOGLYCOPROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION;

RATTUS;

EID: 77955491999     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22649     Document Type: Article

References (69)

1. Akama T, Shida Y, Sugaya T, Ishida H, Gomi K, Kasai M. 1996. Novel 5- aminoflavone derivatives as specific antitumor agents in breast cancer. J Med Chem 39:3461-3469.
2. Anderson JJB, Garner SC. 1998. Phytoestrogens and bone. Bailliere's Clin Endocrinol Metab 12:543-557.
3. Araki S, Mezawa M, Sasaki Y, Yang L, Li Z, Takai H, Nakayama Y, Ogata Y. 2009. Parathyroid hormone regulation of the human bone sialoprotein gene transcription is mediated through two cAMP response elements. J Cell Biochem 106:618-625.
4. Bai F, Matsui T, Ohtani-Fujita N, Matsukawa Y, Ding Y, Sakai T. 1998. Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G1 phase arrest in A549 lung adenocarcinoma cells. FEBS Lett 437:61-64.
5. Barnes GL, Javed A, Waller SM, Kamal MH, Hebert KE, Hassan MQ, Bellahcene A, Van Wijnen AJ, Young MF, Lian JB, Stein GS, Gerstenfeld LC. 2003. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and Msx2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res 63:2631-2637.
6. Benson MD, Aubin JE, Xiao G, Thomas PE, Franceschi RT. 1999. Cloning of a 2.5kb murine bone sialoprotein promoter fragment and functional analysis of putative Osf2 binding sites. J Bone Miner Res 14:396-405.
7. Benson MD, Bargeon JL, Xiao G, Thomas PE, Kim A, Cui Y, Franceschi RT. 2000. Identification of a homeodomain binding element in the bone sialoprotein gene promoter that is required for its osteoblast-selective expression. J Biol Chem 275:13907-13917.
8. Caretti G, Motta MC, Mantovani R. 1999. NF-Y associates with H3-H4 tetramers and octamers by multiple mechanism. Mol Cell Biol 19:8591-8601.
9. Chen J, Shapiro HS, Sodek J. 1992. Development expression of bone sialoprotein mRNA in rat mineralized connective tissues. J Bone Miner Res 7:987-997.
10. Chen S, Unterbrink A, Kadapakkam S, Dong J, Gu TT, Dickson J, Chuang H, MacDougall M. 2004. Regulation of the cell type-specific dentin sialophosphoprotein gene expression in mouse odondoblasts by a novel transcription repressor and an activator CCAAT-binding factor. J Biol Chem 279:2182-42191.
11. Comalada M, Ballester I, Bailón E, Sierra S, Xaus J, Gálvez J, de Medina FS, Zarzuelo A. 2006. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: Analysis of the structure-activity relationship. Biochem Pharmacol 72:1010-1021.
12. Dang ZC, Lowik C. 2005. Dose-dependent effects of phytoestrogens on bone. Trends Endocrinol Metab 16:207-213.
13. Detry C, Lamour V, Castronovo V, Bellahcene A. 2008. CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells. Bone 42:422-431.
14. Devareddy L, Khalil DA, Smith BJ, Lucas EA, Soung do Y, Marlow DD, Arjmandi BH. 2006. Soy moderately improves microstructural properties without affecting bone mass in an ovariectomized rat model of osteoporosis. Bone 38:686-693.
15. Dignam JD, Lebovitz RM, Rosder RG. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489.
16. Fisher LW, Fedarko NS. 2003. Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res 44(Suppl 1): 33-40.
17. Fujita T, Azuma Y, Fukuyama R, Hattori Y, Yoshida C, Koida M, Ogita K, Komori T. 2004. Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3-Akt signaling. J Cell Biol 166:85-95.
18. Ganss B, Kim RH, Sodek J. 1999. Bone sialoprotein. Crit Rev Oral Biol Med 10:79-98.
19. Gerritsen ME, Carley WW, Ranges GE, Shen C, Phan SA, Ligon GF, Perry CA. 1995. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol 147:278-292.
20. Ghosh CN, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG. 2002. Requirement of BMP-2 induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 277:33361-33368.
21. Hämäläinen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. 2007. Antiinflammatory effects of flavonoids: Genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 45673:1-10.
22. Harris SE, Guo D, Harris MA, Krishnaswamy A, Lichtler A. 2003. Transcriptional regulation of BMP-2 activated genes in osteoblasts using gene expression microarray analysis: Role of Dlx2 and Dlx5 transcription factors. Front Biosci 8:1249-1265.
23. Havsteen B. 1983. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32:1141-1148.
24. Hayashi A, Gillen AC, Lott JR. 2000. Effects of daily oral administration of quercetin chalcone and modified citrus pectin on implanted colon-25 tumor growth in balb-c mice. Altern Med Rev 5:546-552.
25. Hunter GK, Goldberg HA. 1993. Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci USA 90:8562-8565.
26. Kaliman P, Vinals F, Tester X, Palacin M, Zorzano A. 1996. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem 271:19146-19151.
27. Kerr JM, Fisher LW, Termine JD, Wang MG, Mcbride OW, Young MF. 1993. The human bone sialoprotein gene (IBSP): Genomic localization and characterization. Genomics 17:408-415.
28. Kim RH, Sodek J. 1999. Transcription of the bone sialoprotein gene is stimulated by v-Src acting through an inverted CCAAT box. Cancer Res 59:565-571.
29. Kim RH, Shapiro HS, Li JJ, Wrana JL, Sodek J. 1994. Characterization of the human bone sialoprotein (BSP) gene and its promoter sequence. Matrix Biol 14:31-40.
30. Kim DS, Takai H, Arai M, Araki S, Mezawa M, Kawai Y, Murota K, Terao J, Ogata Y. 2007. Effects of Quercetin and Quercetin 3-Glucuronide on the Expression of Bone Sialoprotein Gene. J Cell Biochem 101:790-800.
31. Kiyoshima T, Yamauchi M, Wong C, Jheon A, Ganss B, Sodek J. 2002. An L1 element disrupts human bone sialoprotein promoter: Lack of tissue-specific regulation by distalless5 (Dlx5) and runt homeodomain protein 2 (Runx2)/ core binding factor a1 (Cbfa1) elements. Gene 299:205-217.
32. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
33. Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyong HM, Sung JH, Wozney JM, Kim HJ, Ryoo HM. 2003. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-b1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 278:34387-34394.
34. Li JJ, Sodek J. 1993. Cloning and. characterization of the rat bone sialoprotein gene promoter. Biochem J 289:625-629.
35. Li XY, van Huijsduijnen RH, Mantovani R, Benoist C, Mathis D. 1992. Intronexon organization of the NF-Y genes. J Biol Chem 267:8984-8990.
36. Li JJ, Kim RH, Sodek J. 1995. An inverted TATA box directs downstream transcription of the bone sialoprotein gene. Biochem J 310:33-40.
37. Maity SN, Sinha S, Ruteshouser EC, de Crombrugghe B. 1992. Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. J Biol Chem 267:16574-16580.
38. Malaval L, Wada-Guéye NM, Boudiffa M, Fei J, Zirngibl R, Chen F, Laroche N, Roux J, Burt-Pichat B, Duboeuf F, Boivin G, Jurdic P, Lafage-Proust M, Amédée J, Vico L, Rossant J, Aubin JE. 2008. Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med 205:1145-1153.
39. Manna SK, Mukhopadhyay A, Van NT, Aggarwal BB. 1999. Silymarin suppresses TNF-induced activation of NF-kB, c-JUN, N-terminal kinase, and apoptosis. J Immunol 163:6800-6809.
40. Manni I, Mazzaro G, Gurtner A, Mantovani R, Haugwitz U, Krause K, Engeland K, Sacchi A, Soddu S, Piaggio G. 2001. NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest. J Biol Chem 276:5570-5576.
41. Mezawa M, Araki S, Takai H, Sasaki Y, Wang S, Li X, Kim D, Nakayama Y, Ogata Y. 2009. Regulation of human bone sialoprotein gene transcription by platelet-derived growth factor-BB. Gene 435:80-87.
42. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F. 2002. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study. J Bone Miner Res 17:1904-1912.
43. Murota K, Shimizu S, Chujo H, Moon J, Terao J. 2000. Efficiency of absorption and metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2. Arch Biochem Biophys 384:391-397.
44. Murota K, Shimizu S, Miyamoto S, Izumi T, Obata A, Kikuchi M, Terao J. 2002. Unique uptake and transport of isoflavone aglycones by human intestinal Caco-2 cells: Comparison of isoflavonoides and flavonoids. J Nutr 132:1956-1961.
45. Nakashima K, Zhou X, Kunkel G, Zhang Z, Min Deng J, Behringer RR, de Crombrugghe B. 2002. The Novel zinc finger-containing transcription factor is required for osteoblast differentiation and bone formation. Cell 108:17-29.
46. Nakayama Y, Nakajima Y, Kato N, Takai H, Kim D, Arai M, Mezawa M, Araki S, Sodek J, Ogata Y. 2006. Insulin-like growth factor-I increases bone sialoprotein (BSP) expression through fibroblast growth factor-2 response element and homeodomain protein-binding site in the proximal promoter of the BSP gene. J Cell Physiol 208:326-335.
47. Newberry EP, Latifi T, Towler DA. 1998. Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5. Biochemistry 37:16360-16368. (Pubitemid 28536272)
48. Ogata Y. 2008. Bone sialoprotein and its transcriptional regulatory mechanism. J Periodontal Res 43:127-135.
49. Ogata Y, Nakao S, Kim RH, Li JJ, Furuyama S, Sugiya H, Sodek J. 2000. Parathyroid hormone regulation of bone sialoprotein (BSP) gene transcription is mediated through a pituitary specific transcription factor-1 (Pit-1) motif in the rat BSP gene promoter. Matrix Biol 19:395-407.
50. Oldberg Å, Franzén A, Heinegård D. 1986. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cellbinding sequence. Proc Natl Acad Sci USA 83:8819-8823.
51. Oldberg Å, Franzén A, Heinegård D, Pierschbacher M, Ruoslahti E. 1988. Identification of a bone sialoprotein receptor in osteosarcoma cells. J Biol Chem 263:19433-19436.
52. Pang JL, Ricupero DA, Huang S, Fatma N, Singh DP, Romero JR, Chattopadhyay N. 2006. Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells. Biochem Pharmacol 71:818-826.
53. Peng XD, Xu PZ, Chen ML, Harn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, Hay N. 2003. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17:1352-1365.
54. Petilli M, Fiorelli G, Benvenuti S, Frediaini U, Gori F, Brandi ML. 1995. Interactions between ipriflavone and the estrogen receptor. Calcif Tissue Int 56:160-165.
55. Prouillet C, Maziere JC, Maziere C, Wattel A, Brazier M, Kamel S. 2004. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharm 67:1307-1313.
56. Rassi CM, Lieberherr M, Chaumaz G, Pointillart A, Cournot G. 2005. Modulation of osteoclastogenesis in porcine bone marrow cultures by quercetin and rutin. Cell Tissue Res 319:383-393.
57. Rowe PS, de Zoysa PA, Dong R, Wang HR, White KE, Econs MJ, Oudet CL. 2000. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 67:54-68.
58. Sakaue H, Ogawa W, Matsumoto M, Kuroda S, Takata M, Sugimoto T, Spiegelman BM, Kasuga M. 1998. Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kinase. J Biol Chem 273:28945-28952.
59. Samoto H, Shimizu E, Matsuda-Honjyo Y, Saito R, Nakao S, Yamazaki M, Furuyama S, Sugiya H, Sodek J, Ogata Y. 2003. Prostaglandin E2 stimulates bone sialoprotein (BSP) expression through cAMP and FGF2 response elements in the proximal promoter of the rat BSP gene. J Biol Chem 278:28659-28667.
60. Shimizu E, Ogata Y. 2002. Activation of bone sialoprotein gene transcription by flavonoids is mediated through an inverted CCAAT box in ROS 17/2.8 cells. J Cell Biochem 86:35-44.
61. Shimizu E, Nakajima Y, Kato N, Nakayama Y, Samoto H, Ogata Y. 2004. Regulation of rat bone sialoprotein (BSP) gene transcription by enamel matrix derivative. J Periodontol 75:260-267.
62. Shimizu E, Saito R, Nakayama Y, Nakajima Y, Kato N, Takai H, Kim D, Arai M, Simmer J, Ogata Y. 2005. Amelogenin stimulates bone sialoprotein (BSP) expression through FGF2 response element and TGF-β1 activation element in the promoter of the BSP gene. J Periodontol 76:1482-1489.
63. Shimizu E, Nakayama Y, Nakajima Y, Kato N, Takai H, Kim D, Arai M, Saito R, Sodek J, Ogata Y. 2006. Fibroblast growth factor 2 and cyclic AMP synergistically regulate bone sialoprotein gene expression. Bone 39:42-52.
64. Shimizu-Sasaki E, Yamazaki M, Furuyama S, Sugiya H, Sodek J, Ogata Y. 2001. Identification of a novel response element in the rat bone sialoprotein (BSP) gene promoter that mediates constitutive and fibroblast growth factor 2-induced expression of BSP. J Biol Chem 276:5459-5466.
65. Suh KS, Choi EM, Kwon M, Chon S, Oh S, Woo JT, Kim SW, Kim JW, Kim YS. 2009. Kaempferol attenuates 2-deoxy-d-ribose-induced oxidative cell damage in MC3T3-E1 osteoblastic cells. Biol Pharm Bull 32:746-749.
66. Syed F, Khosla S. 2005. Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 328:688-696.
67. Tang X, Zhu X, Liu S, Nicholson RC, Ni X. 2008. Phytoestrogens induce differential estrogen receptor beta-mediated responses in transfected MG-63 cells. Endocrine 34:29-35.
68. Waltregny D, Bellahcène A, Leval XD, Florkin B, Weidle U, Castronovo V. 2000. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers. J Bone Miner Res 15:834-843.
69. Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, Brazier M. 2004. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF-kB and AP-1. J Cell Biochem 92:285-295.0.